An overview of the association between allergy and cancer

International Journal of Cancer

Volumn 118, Issue 12, 2006, Pages 3124-3132

  Turner, Michelle C ^a   Chen, Yue ^a   Krewski, Daniel ^a   Ghadirian, Parviz ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Allergy; Epidemiology; Etiology; Neoplasms

Indexed keywords

ALLERGY; ARTICLE; ASTHMA; BLADDER CANCER; CANCER; CANCER INCIDENCE; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ESOPHAGUS CANCER; GENITAL TRACT CANCER; GLIOMA; HUMAN; LUNG CANCER; MEDLINE; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SELF REPORT; STOMACH CANCER; THYROID MEDULLARY CARCINOMA;

EID: 33646424659     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21752     Document Type: Article

References (205)

1. American Cancer Society. Cancer facts and figures 2004. Atlanta, Georgia, American Cancer Society.
2. Canadian Cancer Society. General cancer statistics. http://www. cancer.ca/ccs/internet/standard/0,2283,3172_14423_langId-en,00.html. Accessed April 16, 2003.
3. Adami H-O, Hunter D, Trichopoulos D. Textbook of cancer epidemiology. New York: Oxford University Press, 2002.
4. Boura P, Kountouras J, Lygidakis NJ. Tumor immunity and immunotherapy. Hepatogastroenterology 2001;48:1040-4.
5. Kripke ML. Immunoregulation of carcinogenesis: past, present, and future. J Natl Cancer Inst 1988;80:722-7.
6. Ehrlich P. Ueber den jetzigen Stand der Karzinomforschung. Ned Tijdschr Geneeskd 1909;1:273-90.
7. Markiewicz MA, Gajewski TF. The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response. Crit Rev Oncog 1999;10:247-60.
8. Kinlen LJ. Immunologic factors. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. Philadelphia: W.B. Saunders. 1982;494-505.
9. Linet MS. Immunologic factors. In: Linet MS, ed. The leukemias: epidemiologic factors. New York: Oxford University Press, 1985;223-30.
10. Dai Q, Zheng W, Ji B-T, Shu X-O, Jin F, Zhu J-L, Gao Y-T. Prior immunity-related medical conditions and pancreatic-cancer risk in shanghai. Int J Cancer 1995;63:337-40.
11. Eriksson NE, Holmen A, Hogstedt B, Mikoczy Z, Hagmar L. A prospective study of cancer incidence in a cohort examined for allergy. Allergy 1995;50:718-22.
12. McWhorter WP. Allergy and risk of cancer. Cancer 1988;62:451-5.
13. Volkers N. Wheezing, sneezing, and cancer risk - still an open door. J Natl Cancer Inst 1999;91:1916-8.
14. Varner AE. The increase in allergic respiratory diseases: survival of the fittest? Chest 2002;121:1308-16.
15. Zacharia B, Sherman P. Atopy, helminths, and cancer. Med Hypotheses 2003;60:1-5.
16. Mulrow C. The medical review article: state of the science. Ann Int Med 1987;106:485-8.
17. Oxman A. Checklists for review articles. Br Med J 1994;309:648-51.
18. Weed D. Methodologic guidelines for review papers. J Natl Cancer Inst 1994;86:1813-4.
19. Woolf S. Review articles and disclosure of methods. Am J Prev Med 1991;7:53-4.
20. Allegra J, Lipton A, Harvey H, Luderer J, Brenner D, Mortel R, Demers L, Gillin M, White D, Trautlein J. Decreased prevalence of immediate hypersensitivity (atopy) in a cancer population. Cancer Res 1976;36:3225-6.
21. Cockroft DW, Klein GJ, Dovevan RE, Copland GM. Is there a negative correlation between malignancy and respiratory atopy? Ann Allergy 1979;43:345-7.
22. Fisherman EW. Does the allergic diathesis influence malignancy? J Allergy Clin Immunol 1960;31:74-8.
23. Johnson KJ. Cancer and allergy. Ann Allergy 1979;43:375.
24. Mackay WD. The incidence of allergic disorders and cancer. Br J Cancer 1966;20:434-7.
25. Meers PD. Allergy and cancer. Lancet 1973;1:884-5.
26. Moussa MAA, Karnik AM, Omar YT, Fenech FF. On the analysis of three-dimensional contingency tables - application to the influence of allergy and age on cancer. Methods Inf Med 1985;24:35-6.
27. Vena JE, Bona JR, Byers TE, Middleton E, Jr., Swanson MK, Graham S. Allergy-related diseases and cancer: an inverse association. Am J Epidemiol 1985;122:66-74.
28. Alderson M. Mortality from malignant disease in patients with asthma. Lancet 1974;2:1475-7.
29. Markowe HLJ, Bulpitt CJ, Shipley MJ, Rose G, Crombie DL, Fleming DM. Prognosis in adult asthma: a national study. BMJ 1987; 295:949-52.
30. Polednak AP. Asthma and cancer mortality. Lancet 1975;2:1147-8.
31. Reynolds P, Kaplan GA. Asthma and cancer. Am J Epidemiol 1987; 125:539-40.
32. Robinette CD, Fraumeni JF, Jr. Asthma and subsequent mortality in world war II veterans. J Chron Dis 1978;31:619-24.
33. Kallen B, Gunnarskog J, Conradson T-B. Cancer risk in asthmatic subjects selected from hospital discharge registry. Eur Respir J 1993;6:694-7.
34. Vesterinen E, Pukkala E, Timonon T, Aromaa A. Cancer incidence among 78 000 asthmatic patients. Int J Epidemiol 1993;22:976-82.
35. Turner MC, Chen Y, Krewski D, Ghadirian P, Thun MJ, Calle EE. Cancer mortality among us men and women with asthma and hay fever. Am J Epidemiol 2005;162:212-21.
36. Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW. Lung function, respiratory symptoms, and mortality: results from the busselton health study. Ann Epidemiol 1999;9:297-306.
37. Lange P, Ulrik C, Vestbo J. Mortality in adults with self-reported asthma. Copenhagen city health study group. Lancet 1996;347:1285-9.
38. Margolis D, Bilker W, Hennessy S, Vittorio C, Santanna J, Strom BL. The risk of malignancy associated with psoriasis. Arch Dermatol 2001;137:778-83.
39. Mills PK, Beeson WL, Fraser GE, Phillips RL. Allergy and cancer: organ site-specific results from the adventist health study. Am J Epidemiol 1992;136:287-95.
40. Vandentorren S, Baldi I, Annesi-Maesano I, Charpin D, Neukirch F, Filleul L, Cantagrel A, Tessier JF. Long-terra mortality among adults with or without asthma in the paarc study. Eur Respir J 2003;21:462-7.
41. Gergen PJ, Turkeltaub PC, Sempos CT. Is allergen skin test reactivity a predictor of mortality? findings from a national cohort. Clin Exp Allergy 2000;30:1717-23.
42. Hughes W, Raitz R. A comparison of cancer occurrence in allergic and nonallergic populations. Ann Allergy 1979;43:163-4.
43. Gabriel R, Dudley BM, Alexander WD. Lung cancer and allergy. Br J Clin Pract 1972;26:202-4.
44. Hallgren R, Arrendal H, Hiesche K, Lundquist G, Nou E, Zetterstrom O. Elevated serum immunoglobulin e in bronchial carcinoma: its relation to the histology and prognosis of the cancer. J Allergy Clin Immunol 1981;67:398-406.
45. McDuffie HH. Atopy and primary lung cancer. Chest 1991;99:404-7.
46. McDuffie HH, Cockroft DW, Talebi Z, Klaassen DJ, Dosman JA. Lower prevalence of positive atopic skin tests in lung cancer patients. Chest 1988;93:241-6.
47. Pavlakou G, Koza T, Karaindros D, Tsarouha E, Arvanitakis M, Efthymiou D, Anagnostopoulou AO. Atopy and its protective role to primary lung cancer. Eur Respir J 1994;18:7.
48. Santillan A, Camargo C, Jr., Colditz G. A meta-analysis of asthma and risk of .lung cancer (United States). Cancer Causes Contr 2003; 14:327-34.
49. Biesalski H, Bueno de Mesquita B, Chesson A, Chytil F, Grinble R, Hermus R, Kohrle J, Lotan R, Norpoth K, Pastorino U, Thurnham D. Consensus statement on lung cancer. Eur J Cancer Prev 1997;6:316-22.
50. Boffetta P, Ye W, Boman G, Nyren O. Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur Respir J 2002;19:127-33.
51. Mayne ST, Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 1999;149:13-20.
52. Farrow DC, Davis S. Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int J Cancer 1990; 45:816-20.
53. Mills PK, Beeson WL, Abbey DE, Fraser GE, Phillips RL. Dietary habits and past medical history as related to fatal pancreas cancer risk among adventists. Cancer 1988;61:2578-85.
54. Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM, Schwartz AG, Brown LM, Greenberg RS, Schoenberg JB, Pottern LM, Hoover RN, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-7.
55. Jain M, Howe GR, St. Louis P, Miller AB. Coffee and alcohol as determinants of risk of pancreas cancer: a case-control study from Toronto. Int J Cancer 1991;47:384-9.
56. Gandini S, Lowenfels A, Jaffee E, Armstrong T, Maisonneuve P. Allergies and the risk of pancreatic cancer, a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomarkers Prev 2005;14:1908-16.
57. Holly EA, Eberle CA, Bracci PM. Prior history of allergies and pancreatic cancer in the san francisco bay area. Am J Epidemiol 2003; 158:432-41.
58. Bernstein L, Ross RK. Prior medication use and health history as risk factors for nonHodgkin's lymphoma: preliminary results from a case-control study in Los Angeles county. Cancer Res 1992;52: 5510s-5s.
59. Briggs NC, Levine RS, Brann EA. Allergies and risk of nonHodgkin's lymphoma by subtype. Cancer Epidemiol Biomarkers Prev 2002;11: 401-7.
60. Doody MM, Linet MS, Glass AG, Friedman GD, Pottern LM, Boice JD, Jr., Fraumeni JF, Jr. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Contr 1992;3:449-56.
61. Fabbro-Peray P, Daures J-P, Rossi J-F. Environmental risk factors for nonHodgkin's lymphoma: a population-based case-control study in Languedoc-Roussillon, France. Cancer Causes Contr 2001;12:201-12.
62. Grulich AE, Vajdic CM, Kaldor JM, Hughes AM, Kricker A, Fritschi L, Turner JJ, Milliken S, Benke G, Armstrong BK. Birth order, atopy, and risk of nonHodgkin lymphoma. J Natl Cancer Inst 2005;97:587-94.
63. Holly EA, Lele C, Bracci PM, McGrath MS. Case-control study of nonHodgkin's lymphoma among women and heterosexual men in the San Francisco Bay area, California. Am J Epidemiol 1999;150:375-89.
64. Holly EA, Lele C. Non-Hodgkin's lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay area. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:211-22.
65. McDuffie HH, Pahwa P, McLaughlin JR, Spinelli JJ, Fincham S, Dosman JA, Robson D, Skinnider LF, Choi NW. Non-Hodgkin's lymphoma and specific pesticide exposures in men: cross-canada study of pesticides and health. Cancer Epidemiol Biomarkers Prev 2001;10: 1155-63.
66. McKinney PA, Alexander FE, Roberts B, O'Brien C, Bird CC, Cartwright RA. Yorkshire case control study of leukemias and lymphomas parallel multivariate analyses of seven disease categories. Leuk Lymphoma 1990;2:67-80.
67. Pearce NE, Sheppard RA, Smith AH, Teague CA. Non-hodgkin's lymphoma and farming: an expanded case-control study. Int J Cancer 1987;39:155-61.
68. Tavani A, La Vecchia C, Franceschi S, Serrraino D, Carbone A. Medical history and risk of Hodgkin's and nonHodgkin's lymphomas. Eur J Cancer 2000;9:59-64.
69. Vineis P, Crosignani P, Sacerdote C, Fontana A, Masala G, Miligi L, Nanni O, Ramazzotti V, Rodella S, Stagnaro E, Tumino R, Vigano C, et al. Haematopoietic cancer and medical history: a multicentre case control study. J Epidemiol Community Health 2000;54:431-6.
70. Soderberg KC, Hagmar L, Schwartzbaum J, Feychting M. Allergic conditions and risk of hematological malignancies in adults: a cohort study. BMC Publ Health 2004;4:51.
71. Amlot PL, Green LA. Atopy and immunoglobulin E concentrations in hodgkin's disease and other lymphomas. BMJ 1978;1:327-9.
72. McCormick DP, Ammann AJ, Ishizaka K, Miller DG, Hong R. A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia. Cancer 1971;27:93-9.
73. Newell GR, Rawlings W, Kinnear K, Correa P, Henderson BE, Dworsky R, Menck H, Thompson R, Sheehan WW. Case-control study of hodgkin's disease. I. Results of the interview questionnaire. J Natl Cancer Inst 1973;51:1437-41.
74. Cooper GS, Kamel F, Sandler DP, Davey FR, Bloomfield CD. Risk of adult acute leukemia in relation to prior immune-related conditions. Cancer Epidemiol Biomarkers Prev 1996;5:867-72.
75. Gibson R, Graham S, Lilienfeld A, Schuman L, Levin M, Swanson M. Epidemiology of diseases in adult males with leukemia. J Natl Cancer Inst 1976;56:891-8.
76. Linet MS, McCaffrey LD, Humphrey RL, Brookmeyer R, Van Natta ML, Tielsch JM, Bias WB, Markowitz JA, Kravitz SC, Szklo M. Chronic lymphocytic leukemia and acquired disorders affecting the immune system: a case-control study. JCNI 1986;77:371-8.
77. Severson RK, Davis S, Thomas DB, Stevens RG, Heuser L, Sever LE. Acute myelocytic leukemia and prior allergies. J Clin Epidemiol 1989; 42:995-1001.
78. Zheng W, Linet MS, Shu X-O, Pan R-P, Gao Y-T, Fraumeni JF, Jr. Prior medical conditions and the risk of adult leukemia in shanghai, people's republic of china. Cancer Causes Contr 1993;4:361-8.
79. Wen W, Shu XO, Linet MS, Neglia JP, Potter JD, Trigg ME, Robison LL. Allergic disorders and the risk of childhood acute lymphoblastic leukemia (United States). Cancer Causes Contr 2000;11:303-7.
80. Nishi M, Miyake H. A case-control study of nonT cell acute lymphoblastic leukaemia of children in Hokkaido, Japan. J Epidemiol Community Health 1989;43:352-5.
81. Petridou E, Trichopoulos D, Kalapothaki V, Pourtsidis A, Kogevinas M, Kalmanti M, Koliouskas D, Kosmidis H, Panagiotou JP, Piperopoulou F, Tzortzatou F. The risk profile of childhood leukaemia in greece: a nationwide case-control study. Br J Cancer 1997;76: 1241-7.
82. Schuz J, Morgan G, Bohler E, Kaatsch P, Michaelis J. Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer 2003;105:255-60.
83. Spector L, Groves F, DeStefano F, Liff J, Mullooly J, Black S, Shinefield H, Ward J, Marcy M, Vaccine data safety project. Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia. Eur J Cancer 2004;40:579-84.
84. Boffetta P, Stellman SD, Garfinkel L. A case-control study of multiple myeloma nested in the american cance society prospective study. Int J Cancer 1989;43:554-9.
85. Bourguet CC, Logue EE. Antigenic stimulation and multiple myeloma. Cancer 1993;72;2148-54.
86. Cuzick J, De Stavola B. Multiple myeloma - a case-control study. Br J Cancer 1988;57:516-20.
87. Eriksson M. Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study. Eur J Cancer 1993;29A:259-63.
88. Gallagher RP, Spinelli JJ, Elwood JM, Skippen DH. Allergies and agricultural exposure as risk factors for multiple myeloma. Br J Cancer 1983;48:853-7.
89. Gramenzi A, Buttino I, D'Avanzo B, Negri E, Franceschi S, La Vecchia C. Medical history and the risk of multiple myeloma. Br J Cancer 1991;63:769-72.
90. Herrinton LJ, Demers PA, Koepsell TD, Weiss NS, Daling JR, Taylor JW, Lyon JL, Swanson GM, Greenberg RS. Epidemiology of the M-component immunoglobulin types of multiple myeloma. Cancer Causes Contr 1993;4:83-92.
91. Keopsell TD, Daling JR, Weiss NS, Taylor JW, Olshan AF, Lyon JL, Swanson GM, Child M. Antigenic stimulation and the occurrence of multiple myeloma. Am J Epidemiol 1987;126:1051-62.
92. Lewis DR, Pottern LM, Brown LM, Silverman DT, Hayes RB, Schoenberg JB, Greenberg RS, Swanson GM, Schwartz AG, Liff J, Hoover RN. Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes Contr 1994;5:529-39.
93. Linet MS, Harlow SD, McLaughlin JK. A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation, and drug use. Cancer Res 1987;47:2978-81.
94. Pearce NE, Smith AH, Howard JK, Sheppard RA, Giles HJ, Teague CA. Case-control study of multiple myeloma and farming. Br J Cancer 1986;54:493-500.
95. Williams AR, Weiss NS, Koepsell TD, Lyon JL, Swanson GM. Infectious and noninfectious exposures in the etiology of light chain myeloma: a case-control study. Cancer Res 1989;49:4038-41.
96. Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002;99:252-9.
97. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Alhbom A, Choi WN, Giles GG, Howe GR, Little J, Menegoz F, et al. Role of medical history in brain tumor development, results from the international adult brain tumor study. Int J Cancer 1999;82:155-60.
98. Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer 2002;98:609-15.
99. Wiemels JL, Wiencke JK, Patoka J, Moghadassi M, Chew T, McMillan A, Miike R, Barger G, Wrensch M. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 2004;64:8468-73.
100. Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Lonn S, Soderberg K, Feychting M. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer 2003;106:423-8.
101. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol 2005;109:93-108.
102. Ryan P, Lee MW, North B, McMichael AJ. Risk factors for tumors of the brain and meninges: results from the adelaide adult brain tumor study. Int J Cancer 1992;51:20-7.
103. Petroianu A, Chaves DNB, De Oliveira O, Jr. Comparative incidence of allergy in the presence or absence of cancer. J Int Med Res 1995; 23:358-63.
104. Montgomery S, Ehlin A, Sparen P, Bjorksten B, Ekbom A. Childhood indicators of susceptibility to subsequent cervical cancer. Br J Cancer 2002;87:989-93.
105. Ghadirian P, Lacroix A, Perret C, Maisonneuve P, Boyle P. Sociodemographic characteristics, smoking, medical and family history, and breast cancer. Cancer Detect Prev 1998;22:485-94.
106. Hedderson MM, Malone KE, Daling JR, White E. Allergy and risk of breast cancer among young women (United States). Cancer Causes Contr 2003;14:619-26.
107. Talbot-Smith A, Fritschi L, Divitini M, Mallon D, Knuiman M. Allergy, atopy, and cancer: a prospective study of the 1981 busselton cohort. Am J Epidemiol 2003;157:606-12.
108. Ohrui T, Yamaya M, Sato T, Matsui T, Sasaki H, Namina T. Risk of prostate cancer in older Japanese asthmatics. J Am Geriatr Soc 2002; 50:202.
109. Swerdlow AJ, Huttly SRA, Smith PG. Testicular cancer and antecedent diseases. Br J Cancer 1987;55:97-103.
110. Henderson BE, Benton B, Jing J, Yu MC, Pike MC. Risk factors for cancer of the testis in young men. Int J Cancer 1979;23:598-602.
111. Morris Brown L, Pottern LM, Hoover RN. Testicular cancer in young men: the search for causes of the epidemic increase in the United States. J Epidemiol Community Health 1987;41:349-54.
112. Ghadirian P, Maisonneuve P, Perret C, Lacroix A, Boyle P. Epidemiology of sociodemographic characteristics, lifestyle, medical history, and colon cancer: a case-control study among french canadians in Montreal. Cancer Detect Prev 1998;22:396-404.
113. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne colorectal cancer study. Cancer Res 1988;48:4399-404.
114. Negri E, Bosetti C, La Vecchia C, Levi F, Tomei F, Franceschi S. Allergy and other selected diseases and risk of colorectal cancer. Eur J Cancer 1999;35:1838-41.
115. Ye W, Chow W-H, Lagergren J, Boffetta P, Boman G, Adami H-O, Nyren O. Risk of adenocaicinomas of the oesophagus and gastric cardia in patients hospitalized for asthma. Br J Cancer 2001;85: 1317-21.
116. Bosetti C, Talamini R, Franceschi S, Negri E, Giacosa A, La Vecchia C. Allergy and the risk of selected digestive and laryngeal neoplasms. Eur J Cancer Prev 2004;13:173-6.
117. Dai Q, Zheng W, Ji B-T, Shu X-O, Jin F, Cheng H-X, Gao Y-T. Prior immunity-related medical conditions and oesophageal cancer risk: a population-based case-control study in Shanghai. Eur J Cancer Prev 1997;6:152-7.
118. Negri E, Ron E, Franceschi S, La Vecchia C, Preston-Martin S, Kolonel L, Kleinerman RA, Mabuchi K, Jin F, Wingren G, Hallquist A, Levi F, et al. Risk factors for medullary thyroid carcinoma: a pooled analysis. Cancer Causes Contr 2002;13:365-72.
119. Miller CT, Neutel CI, Nair RC, Marrett LD, Last JM, Collins WE. Relative importance of risk factors in bladder carcinogenesis. J Chron Dis 1978;31:51-6.
120. Steineck G, Wiholm BE, Gerhardsson de Verder M. Acetaminophen, some other drugs, some diseases and the risk of transistional cell carcinoma. Acta Oncol 1995;34:741-8.
121. Kim W-J, Lee H-L, Lee S-C, Kim YT, Kim H. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol 2000;164:209-13.
122. Annesi-Maesano I, Didier A, Klossek M, Chanal I, Moreau D, Bousquet J. The score for allergic rhinitis (sfar): a simple and valid assessment method in population studies. Allergy 2002;57:107-14.
123. Toren K, Brisman J, Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires: a literature review. Chest 1993; 104:600-8.
124. Wu AH, Fontham ETH, Reynolds P, Greenberg RS, Buffler P, Liff J, Boyd P, Henderson BE, Correa P. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 1995;141:1023-32.
125. Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev Med 2002;53:477-98.
126. Kilpelainen M, Terho EO, Helenius H, Koskenvuo M. Validation on a new questionnaire on asthma, allergic rhinitis, and conjunctivitis in young adults. Allergy 2001;56:377-84.
127. Demissie K, White N, Joseph L, Ernst P. Bayesian estimation of asthma prevalence, and comparison of exercise and questionnaire diagnostics in the absence of a gold standard. Ann Epidemiol 1998;8: 201-8.
128. Jenkins MA, Clarke JR, Carlin JB, Robertson CF, Hopper JL, Dalton MF, Holst DP, Choi K, Giles GG. Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma. Int J Epidemiol 1996;25: 609-16.
129. Joseph C, Foxman B, Leickly F, Peterson E, Ownby D. Prevalence of possible undiagnosed asthma and associated morbidity among urban schoolchildren. J Pediatr 1996;129:735-42.
130. Ninan T, Russell G. Is exercise testing useful in a community based asthma survey? Thorax 1993;48:1218-21.
131. Remes S, Pekkanen J, Remes K, Salonen R, Korppi M. In search of childhood asthma: questionnaire, tests of bronchial hyperresponsiveness, and clinical evaluation. Thorax 2002;57:120-6.
132. Fishwick D, Bradshaw L, Kemp T, Lewis S, Slater T, Crane J, Pearce N. Respiratory questionnaire responses: how they change with time. NZ Med J 1997;110:305-7.
133. Williams HC, Burney PGJ, Pembroke AC, Hay RJ. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. Br J Dermatol 1996;135:12-7.
134. Jarvis D, Luczynska C, Chinn S, Burney P. The association of age, gender and smoking with total ige and specific IgE. Clin Exp Allergy 1995;25:1083-91.
135. Sherrill D, Halonen M, Burrows B. Relationships between total serum ige, atopy, and smoking: a twenty-year follow-up analysis. J Allergy Clin Immunol 1994;94:954-62.
136. Vellutini M, Viegi G, Parrini D, Pedreschi M, Baldacci S, Modena P, Biavati P, Simoni M, Carrozzi L, Giuntini C. Serum immunoglobulins E are related to menstrual cycle. Eur J Epidemiol 1997;13: 931-5.
137. McGill K, Sorkness C, Ferguson-Page C, Gern J, Havighurst T, Knipfer B, Lemanske Rf, Jr., Busse WW. Asthma in noninner city head start children. Pediatrics 1998;102:77-83.
138. Pless C, Pless I. How well they remember. The accuracy of parent reports. Arch Pediatr Adolesc Med 1995;149:553-8.
139. Clark NM, Brown R, Joseph CLM, Anderson EW, Liu M, Valerio M, Gong M. Issues in identifying asthma and estimating prevalence in an urban school population. J Clin Epidemiol 2002;55:870-81.
140. Linet MS, Harlow SD, McLaughlin JK, McCaffrey LD. A comparison of interview data and medical records for previous medical conditions and surgery. J Clin Epidemiol 1989;42:1207-13.
141. Lipworth L, Fryzek JP, Fored CM, Blot WJ, McLaughlin JK. Comparison of surrogate with self-respondents regarding medical history and prior medication use. Int J Epidemiol 2001;30:303-8.
142. Lerchen M, Samet J. An assessment of the validity of questionnaire responses provided by a surviving spouse. Am J Epidemiol 1986;123: 481-9.
143. Balmaceda D, Ciccolo M, Ma Y, Baydur A. Leiomyosarcoma of the trachea masquerading as chronic asthma. Respiration 2002;69:165.
144. Callen J, Bernardi D, Clark R, Weber D. Adult-onset recalcitrant eczema: a marker of noncutaneous lymphoma or leukemia. J Am Acad Dermatol 2000;43:207-10.
145. Clark C. Intrathoracic trachael tumour presenting as asthma. BMJ 1978;1:48.
146. Dhand R, Jindal S, Malik S, Pandit V. Primary carcinoma of the trachea. Indian J Chest Dis Allied Sci 1981;23:47-50.
147. Dipaolo F, Stull M. Bronchial carcinoid presenting as refractory asthma. Am Fam Physician 1993;48:785-9.
148. Elmer K, George R. Cutaneous T-cell lymphoma presenting as benign dermatoses. Am Fam Physician 1999;59:2809-13.
149. Fidias P, Wright C, Harris N, Urba W, Grossbard M. Primary tracheal nonHodgkin's lymphoma. A case report and review of the literature. Cancer 1996;77:2332-8.
150. Heath J. Leukaemia presenting as respiratory distress in a child with asthma. J Paediatr Child Health 2001;37:397-9.
151. Isaacs D, Smyth J, Bradbeer T, Pagliero K. Intrathoracic trachael tumour presenting as asthma. BMJ 1977;2;1332.
152. Levin J, Camisa C. Unresponsive eczematous dermatitis: a case of pancreatic cancer masquerading as cutaneous T cell lymphoma. Cutis 1999;64:113-4.
153. Parrish R, Banks J, Fennerty A. Tracheal obstruction presenting as asthma. Postgrad Med J 1983;59:775-6.
154. Brenner AV, Wang Z, Kleinerman RA, Wang L, Zhang S, Metayer C, Chen K, Lei S, Cui H, Lubin JH. Previous pulmonary diseases and risk of lung cancer in gansu province, China. Int J Epidemiol 2001; 30:118-24.
155. Vesterinen E, Karjalainen S, Timonen T, Pukkala E, Hakulinen T. Survival rates in lung cancer patients with and without bronchial asthma. Acta Oncol 1993;32:517-20.
156. Tammemagi C, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer 2003;103:792-802.
157. Yancik R, Wesley M, Ries L, Havlik R, Edwards B, Yates J. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 and older. JAMA 2001;285:885-92.
158. Yancik R, Wesley M, Ries L, Havlik R, Long S, Edwards B, Yates JW. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 1998;82:2123-34.
159. Vesterinen E, Kaprio J, Koskenvuo M. Prospective study of asthma in relation to smoking habits among 14 729 adults. Thorax 1988;43: 534-9.
160. Ben-Noun L. Is there a relationship between smoking and asthma in adults? J Int Med Res 1999;27:15-21.
161. Bergmann RL, Edenharter G, Bergmann KE, Lau S, Wahn U. Socioeconomic status is a risk factor for allergy in parents but not in their children. Clin Exp Allergy 2000;30:1740-5.
162. Lewis SA, Weiss ST, Platts-Mills TAE, Syring M, Gold DR. Association of specific allergen sensitization with socioeconomic factors and allergic disease in a population of boston women. J Allergy Clin Immunol 2001;107:615-22.
163. Matricardi PM, Franzinelli F, Franco A, Caprio G, Murru F, Cioffi D, Ferrigno L, Palermo A, Ciccarelli N, Rosmini F. Sidship size, birth order, and atopy in 11,371 italian young men. J Allergy Clin Immunol 1998;101:439-44.
164. Williams HC, Strachan DP, Hay RJ. Childhood eczema: disease of the advantaged? BMJ 1994;308:1132-5.
165. Boyd C, Zhang-Salomons J, Groome PA, MacKillop WJ. Associations between community income and cancer survival in Ontario, Canada, and the United States. J Clin Oncol 1999;17:2244-55.
166. MacKillop WJ, Zhang-Salomons J, Boyd CJ, Groome PA. Associations between community income and cancer incidence in Canada and the United States. Cancer 2000;89:901-12.
167. Johnson C, Ownby D, Zoratti E, Alford S, Williams L, Joseph C. Environmental epidemiology of pediatric asthma and allergy. Epidemiol Rev 2002;24:154-75.
168. Karmaus W, Botezan C. Does a Higher number of siblings protect against the development of allergy and asthma? J Epidemiol Community Health 2002;56:209-17.
169. Karmaus W, Johnson C. Invited commentary: sidship effects and a call for a comparative disease approach. Am J Epidemiol 2005;162: 133-8.
170. Westergaard T, Andersen P, Pedersen J, Olsen J, Frisch M, Sorensen H, Wohlfahrt J, Melbye M. Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst 1997;89:939-47.
171. Westergaard T, Melbye M, Pedersen J, Frisch M, Olsen J, Andersen P. Birth order, sidship size and risk of Hodgkin's disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer 1997;72:977-81.
172. Chang E, Montgomery S, Richiardi L, Ehlin A, Ekbom A, Lambe M. Number of siblings and risk of hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2004;13:1236-43.
173. Friedman GD, Coates AO, Potter JD, Slattery ML. Drugs and colon cancer. Pharmacoepidemiol Drug Saf 1998;7:99-106.
174. Hallquist A, Hardell L, Degerman A, Boquist L. Thyroid cancer: reproductive factors, previous diseases, drug intake, family history and diet. A case-control study. Eur J Cancer Prev 1994;3:481-8.
175. Kelly J, Rosenberg L, Palmer J, Rao R, Strom B, Stolley P, Zauber AG. Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines. Am J Epidemiol 1999;150:861-8.
176. Kummet TA, Garewal HS, Moon TE. Xanthine-containing bronchodilators and pancreatic cancer. Lancet 1983;2:231.
177. Nadalin V, Cotterchio M, Kreiger N. Antihistamine use and breast cancer risk. Int J Cancer 2003;10:566-8.
178. Vaughan TL, Farrow DC, Hansten PD, Chow W-H, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H, et al. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Cancer Epidemiol Biomarkers Prev 1998;7:749-56.
179. McCullough ML, Giovannucci EL. Diet and cancer prevention. Oncogene 2004;23:6349-64.
180. Pope III CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine paniculate air pollution. JAMA 2002;287: 1132-41.
181. Siemiatycki J. Risk factors for cancer in the workplace. Boca Raton, FL: CRC Press, 1991.
182. Siemiatycki J, Krewski D, Shi Y, Goldberg M, Nadon L, Lakhani R. Controlling for potential confounding by occupational exposures. J Toxicol Environ Health A 2003;66:1591-603.
183. Lipscomb MF, Wilder JA. Immune dysregulation as a cause for allergic asthma. Curr Opin Pulm Med 1999;5:10-20.
184. Terr AI. The atopic diseases. In: Stiles DP, Terr AI, eds. Basic and clinical immunology. East Norwalk, Connecticut: Appleton & Lange, 1991;380-99.
185. Knopf PM. Immunomodulation and allergy. Allergy Asthma Proc 2000;21:215-20.
186. Krejsek J, Kral B, Vokurkova D, Derner V, Touskova M, Parakova Z, Kopecky O. Decreased peripheral blood γδ T cells in patients with bronchial asthma. Allergy 1998;53:73-7.
187. Timonen T, Stenius-Aarniala B. Natural killer cell activity in asthma. Clin Exp Immunol 1985;59:85-90.
188. Chen YJ, Shyur SD, Wang CY, Huang KY, Chao YK, Chen PG. Comparison of antileukemic immunity against u937 cells in atopic asthmatics versus healthy controls. Neoplasma 1999;46:304-8.
189. Strannegard I, Strannegard O. NK cells and interferon production in atopic dermatitis. Acta Derm Venereol Suppl 1980;92:48-51.
190. Kusaka Y, Sato K, Zhang Q, Morita A, Kasahara T, Yanagihara Y. Association of natural killer cell activity with serum IgE. Int Arch Allergy Immunol 1997;112:331-5.
191. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural cytotoxic activity of peripheral blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 2000; 356:1795-9.
192. Mocellin S, Wang E, Marincola FM. Cytokines and immune response in the tumor microenvironment. J Immunother 2001;24:392-407.
193. Saleh M, Wiegmans A, Malone Q, Stylli S, Kaye A. Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors. J Natl Cancer Inst 1999;91:438-45.
194. Thomson A. The cytokine handbook. London: Academic Press, 1998.
195. Allione A, Consalvo M, Nanni P, Lollini PL, Cavallo F, Giovarelli M, Forni M, Gulino A, Colombo MP, Dellabona P. Immunization and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor a, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants. Cancer Res 1994;54:6022-6.
196. Nishimura T, Iwakabe K, Sekimoto M, Yahata T, Nakui M, Sato T, Habu S, Tashiro H, Sato M, Ohta A. Distinct role of antigen-specific T helper Type 1 (Th1) and Th2 cells in tumor eradication in vivo. J Exp Med 1999;190:627.
197. Tepper RI, Pattengale PK, Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989;57:503-12.
198. Stanciu L. Immunomodulation by histamine. Ann Biol Clin 1990;48: 623-5.
199. Hellstrand K, Brune M, Naredi P, Mellqvist U-H, Hansson M, Gehlsen KR, Hermodsson S. Histamine: a novel approach to cancer immunotherapy. Cancer Invest 2000;18:347-55.
200. Reali E, Breiner JW, Corti A, Gould HJ, Bottazzoli F, Paganelli G, Schlom J, Siccardi AG. IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines. Cancer Res 2001;61:5517-22.
201. Cogan E, Schandene L, Crusiax A, Cochaux P, Velu T, Goldman M. Brief report: clonal proliferation of type 2 helper cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994;350:535-8.
202. Pericle F, Giovarelli M, Colombo MP, Ferrari G, Musiani P, Modesti A, Cavallo F, Di Pierro F, Novello F, Forni G. An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary ademocarcinoma engineered to release IL-4. J Immunol 1994;153:5659-73.
203. Samoszuk M. Eosinophils and human cancer. Histol Histopathol 1997;12:807-12.
204. Gould HJ, Mackay GA, Karagiannis SN, O'Toole C, Marsh PJ, Dan iell BE, Coney LR, Zurawski VRJ, Joseph M, Caprons M, Gilbert M, Murphy GF, et al. Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro in a scid mouse xenograft model of ovarian carcinoma. Eur J Immunol 1999;29:3527-37.
205. Kershaw MH, Darcy PK, Trapani JA, MacGregor D, Smyth MJ. Tumor-specific IgE-mediated inhibition of human colorectal carcinoma xenograft growth. Oncol Res 1998;10:133-42.